Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  8,239 نتائج ل ""Immunotherapy, Adoptive""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Adoptive cell therapy in acute myeloid leukemia: the current landscape and emerging strategies.

  • Authors : Tharakan S; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Tremblay D

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/therapy

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Feb; Vol. 66 (2), pp. 204-217. Date of Electronic Publication: 2024 Oct 25.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults.

  • Authors : Breidenbach M; Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany.; Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. Von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2025 Jan 17; Vol. 18 (1), pp. 8. Date of Electronic Publication: 2025 Jan 17.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantation.

  • Authors : Ohira M; Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.

Subjects: Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/immunology ; Killer Cells, Natural*/Killer Cells, Natural*/Killer Cells, Natural*/transplantation ; Liver Transplantation*/Liver Transplantation*/Liver Transplantation*/adverse effects

  • Source: PloS one [PLoS One] 2025 Jan 16; Vol. 20 (1), pp. e0313102. Date of Electronic Publication: 2025 Jan 16 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis.

  • Authors : Meng F; Department of Hematology, Daping Hospital, Third Military Medical University (Army Medical University), No.10, Daping Changjiang Branch Road, Yuzhong District, Chongqing, 400042, China.; Xiang M

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/immunology ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects

  • Source: BMC cancer [BMC Cancer] 2025 Jan 14; Vol. 25 (1), pp. 78. Date of Electronic Publication: 2025 Jan 14.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy.

  • Authors : Shang Q; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.; Wang Y

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects ; Antigens, CD19*/Antigens, CD19*/Antigens, CD19*/immunology

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Jan; Vol. 66 (1), pp. 54-63. Date of Electronic Publication: 2024 Oct 08.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real-World Characterization of Toxicities and Medication Management in Recipients of CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma in Nova Scotia, Canada.

  • Authors : Shaw J; Department of Pharmacy, Nova Scotia Health, QEII Health Sciences Centre, Halifax, NS B3H 2Y9, Canada.; Elsawy M

Subjects: Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects; Humans

  • Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Dec 24; Vol. 32 (1). Date of Electronic Publication: 2024 Dec 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma.

  • Authors : Zhang R; Department of Hematology, Tianjin First Central Hospital, Tianjin, China.; Zhang Y

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/pathology ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/genetics

  • Source: Journal of translational medicine [J Transl Med] 2025 Jan 22; Vol. 23 (1), pp. 105. Date of Electronic Publication: 2025 Jan 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Application of adoptive cell therapy in malignant melanoma.

  • Authors : Hu Q; Department of Plastic and Reconstructive Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, People's Republic of China.; Xuan J

Subjects: Melanoma*/Melanoma*/Melanoma*/therapy ; Melanoma*/Melanoma*/Melanoma*/immunology ; Melanoma*/Melanoma*/Melanoma*/pathology

  • Source: Journal of translational medicine [J Transl Med] 2025 Jan 22; Vol. 23 (1), pp. 102. Date of Electronic Publication: 2025 Jan 22.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Management of chimeric antigen receptor T-cell-related toxicity of a patient affected by cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, followed by an intestinal perforation: a case report.

Subjects: Cytokine Release Syndrome* ; Intestinal Perforation* ; Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/Neurotoxicity Syndromes*/etiology

  • Source: Journal of medical case reports [J Med Case Rep] 2025 Jan 20; Vol. 19 (1), pp. 27. Date of Electronic Publication: 2025 Jan 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review.

  • Authors : Sassine J; Infectious Diseases Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.; Siegrist EA

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/immunology ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/methods

  • Source: Viruses [Viruses] 2025 Jan 18; Vol. 17 (1). Date of Electronic Publication: 2025 Jan 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  8,239 نتائج ل ""Immunotherapy, Adoptive""